-
1
-
-
0001822934
-
Epidemiology of cardiac disease in dialysis patients
-
Sarnak MJ, Levey AS. Epidemiology of cardiac disease in dialysis patients. Seminars in Nephrology. 1999;12:69-76.
-
(1999)
Seminars in Nephrology
, vol.12
, pp. 69-76
-
-
Sarnak, M.J.1
Levey, A.S.2
-
2
-
-
0038124736
-
Cardiovascular complications in patients with chronic renal insufficiency and chronic kidney failure]
-
Tesar V. [Cardiovascular complications in patients with chronic renal insufficiency and chronic kidney failure]. Vnitr Lek. 2003;49(5):383-387.
-
(2003)
Vnitr Lek
, vol.49
, Issue.5
, pp. 383-387
-
-
Tesar, V.1
-
3
-
-
0031848747
-
Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients
-
Lindholm B, Wang T, Heimburger O, Bergstrom J. Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients. Nephrol Dial Transplant. 1998;13 Suppl 6:66-73.
-
(1998)
Nephrol Dial Transplant
, vol.13
, Issue.SUPPL. 6
, pp. 66-73
-
-
Lindholm, B.1
Wang, T.2
Heimburger, O.3
Bergstrom, J.4
-
4
-
-
19744368621
-
Identifying patients with chronic kidney disease from general practice computer records
-
de LS, Chan T, Stevens P, O'Donoghue D, Hague N, Dzregah B, et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract. 2005;22(3):234-241.
-
(2005)
Fam Pract
, vol.22
, Issue.3
, pp. 234-241
-
-
de, L.S.1
Chan, T.2
Stevens, P.3
O'Donoghue, D.4
Hague, N.5
Dzregah, B.6
-
5
-
-
46349111414
-
Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study)
-
Parikh NI, Hwang SJ, Larson MG, Levy D, Fox CS. Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol. 2008;102(1):47-53.
-
(2008)
Am J Cardiol
, vol.102
, Issue.1
, pp. 47-53
-
-
Parikh, N.I.1
Hwang, S.J.2
Larson, M.G.3
Levy, D.4
Fox, C.S.5
-
6
-
-
0029928215
-
Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
-
Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27(3):347-354.
-
(1996)
Am J Kidney Dis
, vol.27
, Issue.3
, pp. 347-354
-
-
Levin, A.1
Singer, J.2
Thompson, C.R.3
Ross, H.4
Lewis, M.5
-
7
-
-
1642413198
-
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization
-
Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659-663.
-
(2004)
Arch Intern Med
, vol.164
, Issue.6
, pp. 659-663
-
-
Keith, D.S.1
Nichols, G.A.2
Gullion, C.M.3
Brown, J.B.4
Smith, D.H.5
-
8
-
-
26944476003
-
Beyond Framingham: Cardiovascular risk profiling in ESRD
-
McClellan WM, Chertow GM. Beyond Framingham: cardiovascular risk profiling in ESRD. J Am Soc Nephrol. 2005;16(6):1539-1541.
-
(2005)
J Am Soc Nephrol
, vol.16
, Issue.6
, pp. 1539-1541
-
-
McClellan, W.M.1
Chertow, G.M.2
-
9
-
-
0031737649
-
Malnutrition, cardiac disease, and mortality: An integrated point of view
-
Bergstrom J, Lindholm B. Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis. 1998;32(5):834-841.
-
(1998)
Am J Kidney Dis
, vol.32
, Issue.5
, pp. 834-841
-
-
Bergstrom, J.1
Lindholm, B.2
-
10
-
-
33947247891
-
-
de MR, Snijder MB, van der Sman-de Beer, Seidell JC, Boeschoten EW, Krediet RT, et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol. 2007;18(3):967-974.
-
de MR, Snijder MB, van der Sman-de Beer, Seidell JC, Boeschoten EW, Krediet RT, et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol. 2007;18(3):967-974.
-
-
-
-
11
-
-
0027564228
-
Predictors of mortality in hemodialysis patients
-
Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, et al. Predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 1993;3(9):1613-1622.
-
(1993)
J Am Soc Nephrol
, vol.3
, Issue.9
, pp. 1613-1622
-
-
Goldwasser, P.1
Mittman, N.2
Antignani, A.3
Burrell, D.4
Michel, M.A.5
Collier, J.6
-
12
-
-
0141789624
-
Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patientlevel meta-analysis
-
Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, De Jong PE, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patientlevel meta-analysis. Ann Intern Med. 2003;139(4):244-252.
-
(2003)
Ann Intern Med
, vol.139
, Issue.4
, pp. 244-252
-
-
Jafar, T.H.1
Stark, P.C.2
Schmid, C.H.3
Landa, M.4
Maschio, G.5
De Jong, P.E.6
-
13
-
-
4644278069
-
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial
-
Fellstrom B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, et al. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. Kidney Int. 2004;66(4):1549-1555.
-
(2004)
Kidney Int
, vol.66
, Issue.4
, pp. 1549-1555
-
-
Fellstrom, B.1
Holdaas, H.2
Jardine, A.G.3
Holme, I.4
Nyberg, G.5
Fauchald, P.6
-
14
-
-
22844450094
-
Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation
-
Fellstrom B, Jardine AG, Soveri I, Cole E, Neumayer HH, Maes B, et al. Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. Am J Transplant. 2005;5(8):1986-1991.
-
(2005)
Am J Transplant
, vol.5
, Issue.8
, pp. 1986-1991
-
-
Fellstrom, B.1
Jardine, A.G.2
Soveri, I.3
Cole, E.4
Neumayer, H.H.5
Maes, B.6
-
15
-
-
22344458137
-
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
-
Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353(3):238-248.
-
(2005)
N Engl J Med
, vol.353
, Issue.3
, pp. 238-248
-
-
Wanner, C.1
Krane, V.2
Marz, W.3
Olschewski, M.4
Mann, J.F.5
Ruf, G.6
-
16
-
-
0025357286
-
Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin
-
Silberberg J, Racine N, Barre P, Sniderman AD. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol. 1990;6(1):1-4.
-
(1990)
Can J Cardiol
, vol.6
, Issue.1
, pp. 1-4
-
-
Silberberg, J.1
Racine, N.2
Barre, P.3
Sniderman, A.D.4
-
17
-
-
0032572913
-
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
-
Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339(9):584-590.
-
(1998)
N Engl J Med
, vol.339
, Issue.9
, pp. 584-590
-
-
Besarab, A.1
Bolton, W.K.2
Browne, J.K.3
Egrie, J.C.4
Nissenson, A.R.5
Okamoto, D.M.6
-
18
-
-
0030404906
-
Renal findings in patients with short-term type 2 diabetes
-
Keller CK, Bergis KH, Fliser D, Ritz E. Renal findings in patients with short-term type 2 diabetes. J Am Soc Nephrol. 1996;7(12):2627-2635.
-
(1996)
J Am Soc Nephrol
, vol.7
, Issue.12
, pp. 2627-2635
-
-
Keller, C.K.1
Bergis, K.H.2
Fliser, D.3
Ritz, E.4
-
19
-
-
7444221237
-
Preventing microalbuminuria in type 2 diabetes
-
Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 2004;351(19):1941-1951.
-
(2004)
N Engl J Med
, vol.351
, Issue.19
, pp. 1941-1951
-
-
Ruggenenti, P.1
Fassi, A.2
Ilieva, A.P.3
Bruno, S.4
Iliev, I.P.5
Brusegan, V.6
-
20
-
-
34548420712
-
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial
-
Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370(9590):829-840.
-
(2007)
Lancet
, vol.370
, Issue.9590
, pp. 829-840
-
-
Patel, A.1
MacMahon, S.2
Chalmers, J.3
Neal, B.4
Woodward, M.5
Billot, L.6
-
21
-
-
34249899918
-
Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes
-
Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, et al. Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes. Diabetes Care. 2007;30(6):1577-1578.
-
(2007)
Diabetes Care
, vol.30
, Issue.6
, pp. 1577-1578
-
-
Makino, H.1
Haneda, M.2
Babazono, T.3
Moriya, T.4
Ito, S.5
Iwamoto, Y.6
-
22
-
-
0035922444
-
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
-
Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345(12):870-878.
-
(2001)
N Engl J Med
, vol.345
, Issue.12
, pp. 870-878
-
-
Parving, H.H.1
Lehnert, H.2
Brochner-Mortensen, J.3
Gomis, R.4
Andersen, S.5
Arner, P.6
-
23
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
Brenner BM, Cooper ME, de ZD, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861-869.
-
(2001)
N Engl J Med
, vol.345
, Issue.12
, pp. 861-869
-
-
Brenner, B.M.1
Cooper2
ME, D.Z.3
Keane, W.F.4
Mitch, W.E.5
Parving, H.H.6
-
24
-
-
0035922447
-
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851-860.
-
(2001)
N Engl J Med
, vol.345
, Issue.12
, pp. 851-860
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Clarke, W.R.3
Berl, T.4
Pohl, M.A.5
Lewis, J.B.6
-
25
-
-
27744542905
-
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial
-
Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, et al. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol. 2005;16(7):2170-2179.
-
(2005)
J Am Soc Nephrol
, vol.16
, Issue.7
, pp. 2170-2179
-
-
Berl, T.1
Hunsicker, L.G.2
Lewis, J.B.3
Pfeffer, M.A.4
Porush, J.G.5
Rouleau, J.L.6
-
26
-
-
0043201187
-
The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes]
-
Gaede PH, Jepsen PV, Larsen JN, Jensen GV, Parving HH, Pedersen OB. [The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes]. Ugeskr Laeger. 2003;165(26):2658-2661.
-
(2003)
Ugeskr Laeger
, vol.165
, Issue.26
, pp. 2658-2661
-
-
Gaede, P.H.1
Jepsen, P.V.2
Larsen, J.N.3
Jensen, G.V.4
Parving, H.H.5
Pedersen, O.B.6
-
27
-
-
0030893720
-
Renal function in the elderly: Impact of hypertension and cardiac function
-
Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int. 1997;51(4):1196-1204.
-
(1997)
Kidney Int
, vol.51
, Issue.4
, pp. 1196-1204
-
-
Fliser, D.1
Franek, E.2
Joest, M.3
Block, S.4
Mutschler, E.5
Ritz, E.6
-
28
-
-
0030666411
-
An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability
-
Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P. An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant. 1997;12(11):2301-2307.
-
(1997)
Nephrol Dial Transplant
, vol.12
, Issue.11
, pp. 2301-2307
-
-
Farmer, C.K.1
Goldsmith, D.J.2
Cox, J.3
Dallyn, P.4
Kingswood, J.C.5
Sharpstone, P.6
-
29
-
-
0030604561
-
-
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia, Lancet. 1997;349(9069):1857-1863
-
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet. 1997;349(9069):1857-1863.
-
-
-
-
30
-
-
0024370790
-
Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group
-
Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension. 1989;13(5 Suppl):I80-I93.
-
(1989)
Hypertension
, vol.13
, Issue.5 SUPPL.
-
-
Shulman, N.B.1
Ford, C.E.2
Hall, W.D.3
Blaufox, M.D.4
Simon, D.5
Langford, H.G.6
-
31
-
-
0024536369
-
Renal insufficiency in treated essential hypertension
-
Rostand SG, Brown G, Kirk KA, Rutsky EA, Dustan HP. Renal insufficiency in treated essential hypertension. N Engl J Med. 1989;320(11):684-688.
-
(1989)
N Engl J Med
, vol.320
, Issue.11
, pp. 684-688
-
-
Rostand, S.G.1
Brown, G.2
Kirk, K.A.3
Rutsky, E.A.4
Dustan, H.P.5
-
32
-
-
0027231424
-
Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure
-
Hannedouche T, Albouze G, Chauveau P, Lacour B, Jungers P. Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. Am J Kidney Dis. 1993;21(5 Suppl 2):131-137.
-
(1993)
Am J Kidney Dis
, vol.21
, Issue.5 SUPPL. 2
, pp. 131-137
-
-
Hannedouche, T.1
Albouze, G.2
Chauveau, P.3
Lacour, B.4
Jungers, P.5
-
34
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group
-
Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351(9118):1755-1762.
-
(1998)
Lancet
, vol.351
, Issue.9118
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
Dahlof, B.4
Elmfeldt, D.5
Julius, S.6
-
35
-
-
0042885985
-
Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality
-
London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731-1740.
-
(2003)
Nephrol Dial Transplant
, vol.18
, Issue.9
, pp. 1731-1740
-
-
London, G.M.1
Guerin, A.P.2
Marchais, S.J.3
Metivier, F.4
Pannier, B.5
Adda, H.6
-
36
-
-
0029817038
-
Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus
-
Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16(8):978-983.
-
(1996)
Arterioscler Thromb Vasc Biol
, vol.16
, Issue.8
, pp. 978-983
-
-
Lehto, S.1
Niskanen, L.2
Suhonen, M.3
Ronnemaa, T.4
Laakso, M.5
-
37
-
-
0018748311
-
Arterial calcification and pathology in uremic patients undergoing dialysis
-
Ibels LS, Alfrey AC, Huffer WE, Craswell PW, Anderson JT, Weil R III. Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med. 1979;66(5):790-796.
-
(1979)
Am J Med
, vol.66
, Issue.5
, pp. 790-796
-
-
Ibels, L.S.1
Alfrey, A.C.2
Huffer, W.E.3
Craswell, P.W.4
Anderson, J.T.5
Weil III, R.6
-
38
-
-
1942485985
-
Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis
-
Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol. 2004;8(1):54-58.
-
(2004)
Clin Exp Nephrol
, vol.8
, Issue.1
, pp. 54-58
-
-
Matsuoka, M.1
Iseki, K.2
Tamashiro, M.3
Fujimoto, N.4
Higa, N.5
Touma, T.6
-
39
-
-
17144426995
-
Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients
-
Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, et al. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant. 2005;20(4):760-767.
-
(2005)
Nephrol Dial Transplant
, vol.20
, Issue.4
, pp. 760-767
-
-
Yildiz, A.1
Memisoglu, E.2
Oflaz, H.3
Yazici, H.4
Pusuroglu, H.5
Akkaya, V.6
-
40
-
-
0037216095
-
Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study
-
Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003;14(1):159-168.
-
(2003)
J Am Soc Nephrol
, vol.14
, Issue.1
, pp. 159-168
-
-
Wang, A.Y.1
Wang, M.2
Woo, J.3
Lam, C.W.4
Li, P.K.5
Lui, S.F.6
-
41
-
-
0027367239
-
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of artherosclerotic plaques
-
Giachelli CM, Bae N, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of artherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
-
(1993)
J Clin Invest
, vol.92
, pp. 1686-1696
-
-
Giachelli, C.M.1
Bae, N.2
Denhardt, D.T.3
Alpers, C.E.4
Schwartz, S.M.5
-
42
-
-
9644298257
-
Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro
-
Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int. 2004;66(6):2293-2299.
-
(2004)
Kidney Int
, vol.66
, Issue.6
, pp. 2293-2299
-
-
Yang, H.1
Curinga, G.2
Giachelli, C.M.3
-
43
-
-
0030008101
-
Electron beam computer tomography in the evaluation of cardiac calcification in chronic dialysis patients
-
Braun J, Oldendorf M, Moshage W. Electron beam computer tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;27:394-401.
-
(1996)
Am J Kidney Dis
, vol.27
, pp. 394-401
-
-
Braun, J.1
Oldendorf, M.2
Moshage, W.3
-
44
-
-
0027496973
-
Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease
-
Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EB, Freemont TJ, et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int. 1993;44(5):1071-1077.
-
(1993)
Kidney Int
, vol.44
, Issue.5
, pp. 1071-1077
-
-
Hutchison, A.J.1
Whitehouse, R.W.2
Boulton, H.F.3
Adams, J.E.4
Mawer, E.B.5
Freemont, T.J.6
-
45
-
-
31644446801
-
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
-
Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68(4):1815-1824.
-
(2005)
Kidney Int
, vol.68
, Issue.4
, pp. 1815-1824
-
-
Block, G.A.1
Spiegel, D.M.2
Ehrlich, J.3
Mehta, R.4
Lindbergh, J.5
Dreisbach, A.6
-
46
-
-
35349004713
-
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
-
Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int. 2007;72(9):1130-1137.
-
(2007)
Kidney Int
, vol.72
, Issue.9
, pp. 1130-1137
-
-
Suki, W.N.1
Zabaneh, R.2
Cangiano, J.L.3
Reed, J.4
Fischer, D.5
Garrett, L.6
-
47
-
-
20844432154
-
Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)
-
Moe SM, Reslerova M, Ketteler M, O'Neill K, Duan D, Koczman J, et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int. 2005;67(6):2295-2304.
-
(2005)
Kidney Int
, vol.67
, Issue.6
, pp. 2295-2304
-
-
Moe, S.M.1
Reslerova, M.2
Ketteler, M.3
O'Neill, K.4
Duan, D.5
Koczman, J.6
-
48
-
-
0042073223
-
Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis
-
Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial. 2003;16(2):101-105.
-
(2003)
Semin Dial
, vol.16
, Issue.2
, pp. 101-105
-
-
Levin, A.1
-
49
-
-
0030847042
-
Cardiac disease in chronic uremia: Pathogenesis
-
London GM, Parfrey PS. Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther. 1997;4(3):194-211.
-
(1997)
Adv Ren Replace Ther
, vol.4
, Issue.3
, pp. 194-211
-
-
London, G.M.1
Parfrey, P.S.2
-
50
-
-
0028939185
-
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
-
Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47(1):186-192.
-
(1995)
Kidney Int
, vol.47
, Issue.1
, pp. 186-192
-
-
Foley, R.N.1
Parfrey, P.S.2
Harnett, J.D.3
Kent, G.M.4
Martin, C.J.5
Murray, D.C.6
-
51
-
-
33646688887
-
Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging
-
Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int. 2006;69(10):1839-1845.
-
(2006)
Kidney Int
, vol.69
, Issue.10
, pp. 1839-1845
-
-
Mark, P.B.1
Johnston, N.2
Groenning, B.A.3
Foster, J.E.4
Blyth, K.G.5
Martin, T.N.6
-
52
-
-
0025906705
-
Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: A prospective study
-
Pascual J, Teruel JL, Moya JL, Liano F, Jimenez-Mena M, Ortuno J. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol. 1991;35(6):280-287.
-
(1991)
Clin Nephrol
, vol.35
, Issue.6
, pp. 280-287
-
-
Pascual, J.1
Teruel, J.L.2
Moya, J.L.3
Liano, F.4
Jimenez-Mena, M.5
Ortuno, J.6
-
53
-
-
0033159126
-
AT1-receptor blockers in hypertension and heart failure: Clinical experience and future directions
-
Willenheimer R, Dahlof B, Rydberg E, Erhardt L. AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions. Eur Heart J. 1999;20(14):997-1008.
-
(1999)
Eur Heart J
, vol.20
, Issue.14
, pp. 997-1008
-
-
Willenheimer, R.1
Dahlof, B.2
Rydberg, E.3
Erhardt, L.4
-
54
-
-
0028625446
-
DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy
-
Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994;90(6):2622-2628.
-
(1994)
Circulation
, vol.90
, Issue.6
, pp. 2622-2628
-
-
Iwai, N.1
Ohmichi, N.2
Nakamura, Y.3
Kinoshita, M.4
-
55
-
-
0031443817
-
The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk
-
Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens. 1997;15(12 Pt 2):1579-1592.
-
(1997)
J Hypertens
, vol.15
, Issue.12 PART 2
, pp. 1579-1592
-
-
Staessen, J.A.1
Wang, J.G.2
Ginocchio, G.3
Petrov, V.4
Saavedra, A.P.5
Soubrier, F.6
-
56
-
-
0029907529
-
The role of genetic polymorphisms of angiotensinconverting enzyme in the progression of renal diseases
-
Mclaughlin KJ, Harden PN, Ueda S, Boulton-Jones JM, Connell JM, Jardine AG. The role of genetic polymorphisms of angiotensinconverting enzyme in the progression of renal diseases. Hypertension. 1996;28(5):912-915.
-
(1996)
Hypertension
, vol.28
, Issue.5
, pp. 912-915
-
-
Mclaughlin, K.J.1
Harden, P.N.2
Ueda, S.3
Boulton-Jones, J.M.4
Connell, J.M.5
Jardine, A.G.6
-
57
-
-
0036898135
-
Polymorphism of renin-angiotensin system genes in dialysis patients - association with cerebrovascular disease
-
Losito A, Kalidas K, Santoni S, Ceccarelli L, Jeffery S. Polymorphism of renin-angiotensin system genes in dialysis patients - association with cerebrovascular disease. Nephrol Dial Transplant. 2002;17(12):2184-2188.
-
(2002)
Nephrol Dial Transplant
, vol.17
, Issue.12
, pp. 2184-2188
-
-
Losito, A.1
Kalidas, K.2
Santoni, S.3
Ceccarelli, L.4
Jeffery, S.5
-
58
-
-
27644463104
-
VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5
-
Summers AM, Coupes BM, Brennan MF, Ralph SA, Short CD, Brenchley PE. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5. Nephrol Dial Transplant. 2005;20(11):2427-2432.
-
(2005)
Nephrol Dial Transplant
, vol.20
, Issue.11
, pp. 2427-2432
-
-
Summers, A.M.1
Coupes, B.M.2
Brennan, M.F.3
Ralph, S.A.4
Short, C.D.5
Brenchley, P.E.6
-
59
-
-
42549104621
-
Urinary IL-18 and NGAL as Early Predictive Biomarkers in Contrast-Induced Nephropathy after Coronary Angiography
-
Ling W, Zhaohui N, Ben H, Leyi G, Jianping L, Huili D, et al. Urinary IL-18 and NGAL as Early Predictive Biomarkers in Contrast-Induced Nephropathy after Coronary Angiography. Nephron Clin Pract. 2008;108(3):c176-c181.
-
(2008)
Nephron Clin Pract
, vol.108
, Issue.3
-
-
Ling, W.1
Zhaohui, N.2
Ben, H.3
Leyi, G.4
Jianping, L.5
Huili, D.6
-
60
-
-
0042410539
-
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme
-
Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362(9386):759- 766.
-
(2003)
Lancet
, vol.362
, Issue.9386
, pp. 759-766
-
-
Pfeffer, M.A.1
Swedberg, K.2
Granger, C.B.3
Held, P.4
McMurray, J.J.5
Michelson, E.L.6
-
61
-
-
0035818884
-
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
-
Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345(23):1667-1675.
-
(2001)
N Engl J Med
, vol.345
, Issue.23
, pp. 1667-1675
-
-
Cohn, J.N.1
Tognoni, G.2
-
62
-
-
0037461066
-
The COOPERATE trial
-
Presne C, Mansour J, Makdassi R, Choukroun G, Fournier A. The COOPERATE trial. Lancet. 2003;361(9362):1054.
-
(2003)
Lancet
, vol.361
, Issue.9362
, pp. 1054
-
-
Presne, C.1
Mansour, J.2
Makdassi, R.3
Choukroun, G.4
Fournier, A.5
-
63
-
-
0034627208
-
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
-
Mogensen CE, Neldam S, Tikkanen I, Oren S, Viskoper R, Watts RW, et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ. 2000;321(7274):1440-1444.
-
(2000)
BMJ
, vol.321
, Issue.7274
, pp. 1440-1444
-
-
Mogensen, C.E.1
Neldam, S.2
Tikkanen, I.3
Oren, S.4
Viskoper, R.5
Watts, R.W.6
-
64
-
-
49149087718
-
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial
-
Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008;372(9638):547-553.
-
(2008)
Lancet
, vol.372
, Issue.9638
, pp. 547-553
-
-
Mann, J.F.1
Schmieder, R.E.2
McQueen, M.3
Dyal, L.4
Schumacher, H.5
Pogue, J.6
-
65
-
-
44449104142
-
Prognostic significance of renal function in patients undergoing dobutamine stress echocardiography
-
Karagiannis SE, Feringa HH, Elhendy A, van DR, Chonchol M, Vidakovic R, et al. Prognostic significance of renal function in patients undergoing dobutamine stress echocardiography. Nephrol Dial Transplant. 2008;23(2):601-607.
-
(2008)
Nephrol Dial Transplant
, vol.23
, Issue.2
, pp. 601-607
-
-
Karagiannis, S.E.1
Feringa, H.H.2
Elhendy, A.3
van, D.R.4
Chonchol, M.5
Vidakovic, R.6
-
66
-
-
33847292348
-
Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease
-
Bergeron S, Hillis GS, Haugen EN, Oh JK, Bailey KR, Pellikka PA. Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease. Am Heart J. 2007;153(3):385-391.
-
(2007)
Am Heart J
, vol.153
, Issue.3
, pp. 385-391
-
-
Bergeron, S.1
Hillis, G.S.2
Haugen, E.N.3
Oh, J.K.4
Bailey, K.R.5
Pellikka, P.A.6
|